In a statement about the effectiveness of its Corona vaccine, Astraznica, which manufactured an anti-Corona vaccine with its name, said it was up to 79 percent effective against symptomatic infection.

In a statement, the company added that its vaccine was effective against severe cases and those requiring 100 percent hospital treatment.

AstraZenka based its figures on extensive clinical trials involving 32 thousand people in the United States, Peru and Chile.

These results would further enhance confidence in the vaccine developed by the University of Oxford and dispel the fears and accusations that have affected it in recent weeks.

Astra Z denied that its vaccine included ingredients derived from pork, after the Religious Scholars Council of Indonesia had protected the vaccine, claiming that there was a substance of pork in the vaccine.

It should be noted that, prior to this, many European States suspended the use of the vaccine after reports of its association with blood clots, but returned to use after medical authorities had confirmed its safety.

But a survey published his findings showed that Europeans still question his safety.

Kellogg stated that the experiment showed that the vaccine did not carry side effects, nor did it show any safety concerns.

In an effort to reassure people more, the company said that an independent commission had found no evidence showing an increased risk of blood clots among 21,000 people receiving the first dose of the vaccine.

The AstraZeneca vaccine was among the first and cheapest COFID-19 vaccines developed and produced in large quantities and is to become a major vaccine in vaccination programmes in many developing countries.